CHIKUNGUNYA VIRUS INFECTION

Clinical trials for CHIKUNGUNYA VIRUS INFECTION explained in plain language.

Never miss a new study

Get alerted when new CHIKUNGUNYA VIRUS INFECTION trials appear

Sign up with your email to follow new studies for CHIKUNGUNYA VIRUS INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2 Not yet finished but already full! 6 Completed 1

Healthy volunteers help test new chikungunya drug safety

Knowledge-focused Completed

This early-stage study tested a single dose of an experimental drug called SAR440894 in 42 healthy adults aged 18 to 45. The main goal was to check if the drug is safe and how the body processes it. Participants were randomly assigned to receive either the drug or a placebo, and …

Matched conditions: CHIKUNGUNYA VIRUS INFECTION

Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused

Last updated May 17, 2026 12:56 UTC

CHIKUNGUNYA VIRUS INFECTION

Get alerted when new CHIKUNGUNYA VIRUS INFECTION trials appear

Healthy volunteers help test new chikungunya drug safety